See more : South32 Limited (S32.L) Income Statement Analysis – Financial Results
Complete financial analysis of HilleVax, Inc. (HLVX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HilleVax, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Spod Lithium Corp. (SPOD.CN) Income Statement Analysis – Financial Results
- Limestone Bancorp, Inc. (LMST) Income Statement Analysis – Financial Results
- Koninklijke Ahold Delhaize N.V. (AD.AS) Income Statement Analysis – Financial Results
- LBG Media plc (LBG.L) Income Statement Analysis – Financial Results
- RediShred Capital Corp. (RDCPF) Income Statement Analysis – Financial Results
HilleVax, Inc. (HLVX)
About HilleVax, Inc.
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 2.16M | 2.25M | 3.00K | 0.00 | 0.00 |
Gross Profit | -2.16M | -2.25M | -3.00K | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 106.68M | 45.91M | 10.01M | 0.00 | 0.00 |
General & Administrative | 26.66M | 16.71M | 5.76M | 1.30M | 633.00K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 632.37K |
SG&A | 26.66M | 16.71M | 5.76M | 1.30M | 633.00K |
Other Expenses | 0.00 | -94.70M | -20.23M | -779.00K | 0.00 |
Operating Expenses | 133.35M | 62.61M | 15.77M | 1.30M | 633.00K |
Cost & Expenses | 133.35M | 62.61M | 15.77M | 1.30M | 633.00K |
Interest Income | 9.71M | 3.88M | 2.84K | 29.00 | 9.00 |
Interest Expense | 2.39M | 3.41M | 2.84M | 29.00K | 9.00K |
Depreciation & Amortization | 879.00K | 2.25M | 3.00K | 1.30M | 633.00K |
EBITDA | -132.47M | -65.11M | -99.56M | -2.07M | -31.00K |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -133.35M | -65.11M | -53.43M | -1.30M | -633.00K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 9.78M | -94.70M | -48.98M | -808.00K | -40.00K |
Income Before Tax | -123.57M | -159.81M | -102.41M | -2.10M | -673.00K |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 97.20M | -17.38M | 29.00K | -633.00 |
Net Income | -123.57M | -257.01M | -85.03M | -2.13M | -673.00K |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -3.04 | -6.83 | -2.82 | -0.07 | -0.02 |
EPS Diluted | -3.04 | -6.83 | -2.82 | -0.07 | -0.02 |
Weighted Avg Shares Out | 40.60M | 37.66M | 30.19M | 30.19M | 30.19M |
Weighted Avg Shares Out (Dil) | 40.60M | 37.66M | 30.19M | 30.19M | 30.19M |
Stakeholders Of HilleVax Inc Are Encouraged By The Schall Law Firm To Participate In The Alleged Securities Fraud Investigation
HilleVax, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - HLVX
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Shareholder Rights Advocates at Levi & Korsinsky Investigate HilleVax, Inc. (HLVX) Regarding Possible Securities Fraud Violations
HKVX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm Today!
ATTENTION HLVX SHAREHOLDERS: Investors who lost money on HilleVax, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
HLVX Investors Are Invited By The Schall Law Firm To Join Its Investigation Into Alleged Securities Fraud At HilleVax Inc.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HilleVax, Inc. - HLVX
Levi & Korsinsky Investigates Possible Securities Fraud Violations by HilleVax, Inc. (HLVX)
HKVX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm Today!
Source: https://incomestatements.info
Category: Stock Reports